1. Liu, Tian, Wang, Yubing, Wang, Yiwei, Tsui, Stephen Kwok-Wing, Chan, Andrew M. 2022. The mitotic regulator RCC2 promotes glucose metabolism through BACH1-dependent transcriptional upregulation of hexokinase II in glioma. In Cancer letters, 549, 215914. doi:10.1016/j.canlet.2022.215914. https://pubmed.ncbi.nlm.nih.gov/36116740/
2. Wang, Shenghan, Lei, Zhentao, Liu, Wei, Le, Kai, Zhang, Bao. 2023. RCC2 promotes prostate cancer cell proliferation and migration through Hh/GLI1 signaling pathway and cancer stem-like cells. In Biology direct, 18, 80. doi:10.1186/s13062-023-00439-w. https://pubmed.ncbi.nlm.nih.gov/38008751/
3. Wang, Weiqi, Xu, Bing, Zhang, Zhaoxu, Fang, Kehua, Chang, Xiaotian. 2020. RCC2 Expression Stimulates ER-Positive Breast Tumorigenesis. In Journal of oncology, 2020, 5619462. doi:10.1155/2020/5619462. https://pubmed.ncbi.nlm.nih.gov/32565805/
4. Song, C, Liang, L, Jin, Y, Yun, C-H, Yin, Y. 2017. RCC2 is a novel p53 target in suppressing metastasis. In Oncogene, 37, 8-17. doi:10.1038/onc.2017.306. https://pubmed.ncbi.nlm.nih.gov/28869598/
5. Buranjiang, Gulimire, Abuduwanke, Ailikemu, Li, Xiaowen, Abulizi, Guzalinuer. 2023. LncRNA HOTAIR enhances RCC2 to accelerate cervical cancer progression by sponging miR-331-3p. In Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 25, 1650-1660. doi:10.1007/s12094-022-03059-4. https://pubmed.ncbi.nlm.nih.gov/36593385/
6. Yu, Hai, Zhang, Suojun, Ibrahim, Ahmed N, Deng, Zhong, Wang, Maode. 2019. RCC2 promotes proliferation and radio-resistance in glioblastoma via activating transcription of DNMT1. In Biochemical and biophysical research communications, 516, 999-1006. doi:10.1016/j.bbrc.2019.06.097. https://pubmed.ncbi.nlm.nih.gov/31277942/